Red blood cell folate and plasma folate are not associated with risk of incident colorectal cancer in the Women's Health Initiative observational study.

PubWeight™: 0.77^‹?›

🔗 View Article (PMID 25643945)

Published in Int J Cancer on February 24, 2015

Authors

Marian L Neuhouser¹^,2, Ting-Yuan David Cheng¹^,2^,3, Shirley A A Beresford¹^,2, Elissa Brown¹, Xiaoling Song¹, Joshua W Miller⁴^,5, Yingye Zheng¹, Cynthia A Thomson⁶, James M Shikany⁷, Mara Z Vitolins⁸, Thomas Rohan⁹, Ralph Green⁵, Cornelia M Ulrich¹^,10

Author Affiliations

1: Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA.
2: Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA.
3: Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY.
4: Department of Nutritional Sciences, School of Environmental and Biological Sciences, Rutgers University, New Brunswick, NJ.
5: Department of Medical Pathology and Laboratory Medicine, School of Medicine, University of California, Davis, Sacramento, CA.
6: Canyon Ranch Center for Prevention and Health Promotion, University of Arizona, Tucson, AZ.
7: Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL.
8: Department of Epidemiology and Prevention, Wake Forest School of Medicine, Winston-Salem, NC.
9: Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY.
10: Population Sciences, Huntsman Cancer Institute, Salt Lake City, UT.

Articles citing this ↘

Folate-mediated one-carbon metabolism genes and interactions with nutritional factors on colorectal cancer risk: Women's Health Initiative Observational Study. Cancer (2015) 0.78

Folic acid causes higher prevalence of detectable unmetabolized folic acid in serum than B-complex: a randomized trial. Eur J Nutr (2015) 0.78

People with low serum folate levels have higher risk of colorectal adenoma/advanced colorectal adenoma occurrence and recurrence in China. J Int Med Res (2016) 0.76

Articles cited by this ↗

Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials (1998) 20.39

Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA (2007) 7.93

Implementation of the Women's Health Initiative study design. Ann Epidemiol (2003) 7.30

Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002. Pediatrics (2005) 4.91

Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. Am J Epidemiol (2008) 4.28

Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Gastroenterology (2007) 4.06

Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med (1998) 3.73

Folate, methionine, and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst (1993) 3.25

A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev (2007) 2.91

Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals. Lancet (2013) 2.37

Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J Nutr (2006) 2.25

Folate intake and colorectal cancer risk: a meta-analytical approach. Int J Cancer (2005) 2.11

A mathematical model gives insights into nutritional and genetic aspects of folate-mediated one-carbon metabolism. J Nutr (2006) 1.82

Effects of dietary folate on intestinal tumorigenesis in the apcMin mouse. Cancer Res (2000) 1.81

Vitamin supplements and cancer risk: the epidemiologic evidence. Cancer Causes Control (1997) 1.75

Folate and DNA methylation: a mechanistic link between folate deficiency and colorectal cancer? Cancer Epidemiol Biomarkers Prev (2004) 1.72

Folate supplementation: too much of a good thing? Cancer Epidemiol Biomarkers Prev (2006) 1.68

Plasma folate and risk of colorectal cancer in a nested case-control study: the Japan Public Health Center-based prospective study. Cancer Causes Control (2007) 1.59

The influence of folate and multivitamin use on the familial risk of colon cancer in women. Cancer Epidemiol Biomarkers Prev (2002) 1.57

Chemopreventive effects of dietary folate on intestinal polyps in Apc+/-Msh2-/- mice. Cancer Res (2000) 1.56

Pooled analyses of 13 prospective cohort studies on folate intake and colon cancer. Cancer Causes Control (2010) 1.22

Plasma folate, related genetic variants, and colorectal cancer risk in EPIC. Cancer Epidemiol Biomarkers Prev (2010) 1.18

Obesity and the risk for premenopausal and postmenopausal breast cancer. Cancer Prev Res (Phila) (2012) 1.16

Folic acid fortification and supplementation--good for some but not so good for others. Nutr Rev (2007) 1.15

One-carbon metabolism biomarkers and risk of colon and rectal cancers. Cancer Epidemiol Biomarkers Prev (2008) 1.14

Plasma levels of B vitamins and colorectal cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev (2009) 1.11

Mathematical modeling of folate metabolism: predicted effects of genetic polymorphisms on mechanisms and biomarkers relevant to carcinogenesis. Cancer Epidemiol Biomarkers Prev (2008) 1.08

Pre- and postfortification intake of folate and risk of colorectal cancer in a large prospective cohort study in the United States. Am J Clin Nutr (2011) 1.01

Does folic acid supplementation prevent or promote colorectal cancer? Results from model-based predictions. Cancer Epidemiol Biomarkers Prev (2008) 1.00

B vitamin intakes and incidence of colorectal cancer: results from the Women's Health Initiative Observational Study cohort. Am J Clin Nutr (2012) 0.95

Effects of folate supplementation on two provisional molecular markers of colon cancer: a prospective, randomized trial. Am J Gastroenterol (2001) 0.93

Plasma folate, methylenetetrahydrofolate reductase (MTHFR), and colorectal cancer risk in three large nested case-control studies. Cancer Causes Control (2012) 0.92

Folic acid fortification: a double-edged sword. Curr Opin Clin Nutr Metab Care (2009) 0.90

Epithelial cell folate depletion occurs in neoplastic but not adjacent normal colon mucosa. Gastroenterology (1997) 0.90

Mathematical modeling predicts the effect of folate deficiency and excess on cancer-related biomarkers. Cancer Epidemiol Biomarkers Prev (2011) 0.86

Impact of the MTHFR C677T polymorphism on colorectal cancer in a population with low genetic variability. Int J Colorectal Dis (2013) 0.86

Folic acid fortification and colorectal cancer risk. Am J Prev Med (2014) 0.84

Prospective study of alcohol consumption and the risk of colorectal cancer before and after folic acid fortification in the United States. Ann Epidemiol (2013) 0.82

Articles by these authors ⇆

Dietary biomarker evaluation in a controlled feeding study in women from the Women's Health Initiative cohort. Am J Clin Nutr (2016) 0.91

Dietary Total Isoflavone Intake Is Associated With Lower Systolic Blood Pressure: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. J Clin Hypertens (Greenwich) (2015) 0.77

Estrogen Plus Progestin and Lung Cancer: Follow-up of the Women's Health Initiative Randomized Trial. Clin Lung Cancer (2015) 0.76

Effect of fish oil on monoepoxides derived from fatty acids during cardiac surgery. J Lipid Res (2016) 0.75

Artificially sweetened beverages, sugar-sweetened beverages, plain water, and incident diabetes mellitus in postmenopausal women: the prospective Women's Health Initiative observational study. Am J Clin Nutr (2017) 0.75

Dietary long-chain fatty acids and carbohydrate biomarker evaluation in a controlled feeding study in participants from the Women's Health Initiative cohort. Am J Clin Nutr (2017) 0.75